Systemic immune-inflammation index as a prognostic marker for chronic Hepatitis B with non-alcoholic fatty liver disease.
This study suggests that SII is a relevant risk factor for cirrhosis development in CHB individuals with NAFLD, emphasizing the importance of considering SII in current clinical management.
Authors
- Zeyu Wang (ORCID: https://orcid.org/0000-0002-3373-900X)
- Bo Xue (ORCID: https://orcid.org/0009-0002-8714-1772)
- Lingling Jiang (ORCID: https://orcid.org/0009-0002-5473-8214)
Institutions
- Shanxi Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- The Journal of Infection in Developing Countries
- Published
- 2025-02-28
- DOI
- https://doi.org/10.3855/jidc.19636
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35